Combined CT-Based Radiomics and Clinic-Radiological Characteristics for Preoperative Differentiation of Solitary-Type Invasive Mucinous and Non-Mucinous Lung Adenocarcinoma
Rong Hong,Xiaoxia Ping,Yuanying Liu,Feiwen Feng,Su Hu,Chunhong Hu
DOI: https://doi.org/10.2147/ijgm.s479978
IF: 2.145
2024-09-22
International Journal of General Medicine
Abstract:Rong Hong, 1, 2, &ast Xiaoxia Ping, 2, 3, &ast Yuanying Liu, 2 Feiwen Feng, 2 Su Hu, 2, 3 Chunhong Hu 2, 3 1 Department of Radiology, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, Jiangsu, 215100, People's Republic of China; 2 Department of Radiology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, 215006, People's Republic of China; 3 Institute of Medical Imaging, Soochow University, Suzhou, Jiangsu, 215006, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chunhong Hu; Su Hu, Department of Radiology, The First Affiliated Hospital of Soochow University; Institute of Medical Imaging, Soochow University, Suzhou, Jiangsu, People's Republic of China, Email ; Purpose: The clinical, pathological, gene expression, and prognosis of invasive mucinous adenocarcinoma (IMA) differ from those of invasive non-mucinous adenocarcinoma (INMA), but it is not easy to distinguish these two. This study aims to explore the value of combining CT-based radiomics features with clinic-radiological characteristics for preoperative diagnosis of solitary-type IMA and to establish an optimal diagnostic model. Methods: In this retrospective study, a total of 220 patients were enrolled and randomly assigned to a training cohort (n = 154; 73 IMA and 81 INMA) and a testing cohort (n = 66; 31 IMA and 35 INMA). Radiomics features and clinic-radiological characteristics were extracted from plain CT images. The radiomics models for predicting solitary-type IMA were developed by three classifiers: linear discriminant analysis (LDA), logistic regression-least absolute shrinkage and selection operator (LR-LASSO), and support vector machine (SVM). The combined model was constructed by integrating radiomics and clinic-radiological features with the best performing classifier. Receiver operating characteristic (ROC) curves were used to evaluate models' performance, and the area under the curve (AUC) were compared by the DeLong test. Decision curve analysis (DCA) was conducted to assess the clinical utility. Results: Regarding CT characteristics, tumor lung interface, and pleural retraction were the independent risk factors of solitary-type IMA. The radiomics model using the SVM classifier outperformed the other two classifiers in the testing cohort, with an AUC of 0.776 (95% CI: 0.664– 0.888). The combined model incorporating radiomics features and clinic-radiological factors was the optimal model, with AUCs of 0.843 (95% CI: 0.781– 0.906) and 0.836 (95% CI: 0.732– 0.940) in the training and testing cohorts, respectively. Conclusion: The combined model showed good ability in predicting solitary-type IMA and can provide a non-invasive and efficient approach to clinical decision-making. Keywords: computed tomography, invasive mucinous adenocarcinoma, radiomics, machine learning Lung cancer is a major contributor to cancer-related deaths, with adenocarcinoma being the most predominant subtype. 1 Invasive mucinous adenocarcinoma (IMA) is a unique variant of lung adenocarcinoma, less common than invasive non-mucinous adenocarcinoma (INMA), accounting for approximately 2–5% of lung adenocarcinoma. 2,3 IMA and INMA are two distinct entities. As the name suggests, IMA is characterized as abnormal intracytoplasmic mucin production by columnar and goblet cells, which is rarely observed in INMA. 4 Additionally, IMA exhibits distinct molecular features, with KRAS mutations being the most frequent oncogenic driver mutation (63% to 90%), followed by NRG1 fusions and ERBB2. 4–6 However, EGFR mutations, the most common oncogenic driver mutation in INMA, are notably rare in IMA. The recurrence rate of intrapulmonary IMA is higher than that of INMA, which is associated with a higher incidence of the spread through air spaces (STAS). 7,8 These distinct characteristics of IMA necessitate different treatment approaches compared to INMA. The precise clinical diagnosis of IMA is essential for guiding treatment and predicting the prognosis of patients. Due to the cytologic usually inconspicuous or absent atypia, definitive diagnosis of IMA through biopsy is normally challenged. 9 In contrast, computed tomography (CT) offers a non-invasive examination technique that provides a comprehensive and direct overview of the entire tumor. The common clinical symptoms of IMA include cough, chest pain, and chest congestion. 10,11 Coughing up with white, foamy sputum occurs more frequently in INMA and can sometimes be the primary symptom of IMA. These c -Abstract Truncated-
medicine, general & internal